First Human Trial of Coronavirus Vaccine Has Begun
Testing of an experimental COVID-19 vaccine began in healthy volunteers in Britain Thursday, the latest in a cluster of early-stage studies in search of protection against the coronavirus.
Two volunteers were injected, the first of more than 800 people recruited for the study.
Researchers created the new vaccine by inserting genes for a spikey protein that studs the outer surface of the new coronavirus into another, harmless virus.
Elisa Granato, one of the two who received the jab, told the BBC: “I’m a scientist, so I wanted to try to support the scientific process wherever I can.”
“Personally I have a high degree of confidence in this vaccine,” she said.
“Of course, we have to test it and get data from humans. We have to demonstrate it actually works and stops people getting infected with coronavirus before using the vaccine in the wider population.”
Dozens of vaccine candidates are in various stages of development around the world. Experts have cautioned that even if early studies go well, it will be at least a year before any are available for widespread use.